Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer

Fig. 3

Immunohistochemistry of colXα1. a Representative colXα1 immunostaining in low- and high- colXα1 expressing ER+/HER2+ breast cancers. Two representative cases, one with no response, RCBIII, and strong colXα1 signal, score = 2, and one with good response, RCB0, and no colXα1 signal, score = 0, are shown. Arrows indicate regions with tumor cells. b RNA levels as determined by the microarray correlate with colXα1 IHC signal in 9 cases

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us